Sunshine Biopharma (SBFM) Short Interest Ratio & Short Volume → The most important AI company you've never heard of (From Manward Press) (Ad) Free SBFM Stock Alerts $0.89 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Sunshine Biopharma Short Interest DataCurrent Short Volume284,500 sharesPrevious Short Volume69,800 sharesChange Vs. Previous Month+307.59%Dollar Volume Sold Short$248,937.50Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Outstanding Shares990,000 sharesFloat Size953,400 sharesShort Percent of Float29.84%Today's Trading Volume2,750,940 sharesAverage Trading Volume1,837,292 sharesToday's Volume Vs. Average150% Short Selling Sunshine Biopharma ? Sign up to receive the latest short interest report for Sunshine Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSBFM Short Interest Over TimeSBFM Days to Cover Over TimeSBFM Percentage of Float Shorted Over Time Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects Sunshine Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024284,500 shares $248,937.50 +307.6%29.8%0.1 $0.88 4/15/202469,800 shares $426,478.00 -90.1%7.3%0.1 $6.11 3/31/2024706,700 shares $42,755.35 -27.2%0.8%0 $0.06 3/15/2024971,000 shares $58,260.00 +118.1%1.1%0.1 $0.06 2/29/2024445,300 shares $24,669.62 -26.1%1.0%0 $0.06 2/15/2024602,600 shares $38,265.10 +487.3%1.3%0.3 $0.06 Get the Latest News and Ratings for SBFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024102,600 shares $26,265.60 -9.1%0.4%0.5 $0.26 1/15/2024112,900 shares $28,642.73 -1.6%0.5%0.7 $0.25 12/31/2023114,700 shares $31,141.05 +90.5%0.5%0.7 $0.27 12/15/202360,200 shares $14,327.60 -18.9%0.3%0.4 $0.24 11/30/202374,200 shares $21,443.80 -22.4%0.3%0.5 $0.29 11/15/202395,600 shares $26,194.40 -29.2%0.4%0.7 $0.27 10/31/2023135,100 shares $40,421.92 -35.0%0.6%0.9 $0.30 10/15/2023207,700 shares $66,443.23 +8.6%1.0%1.3 $0.32 9/30/2023191,200 shares $61,184.00 +3.4%0.9%1.1 $0.32 9/15/2023184,900 shares $73,368.32 -34.3%0.9%1.1 $0.40 8/31/2023281,200 shares $120,606.68 -52.5%1.3%1.5 $0.43 8/15/2023591,900 shares $307,788.00 +701.0%2.8%2.7 $0.52 7/31/202373,900 shares $37,689.00 -52.7%0.4%0.1 $0.51 7/15/2023156,300 shares $75,070.89 -32.2%0.9%0.1 $0.48 6/30/2023230,500 shares $113,982.25 -28.9%1.3%0.2 $0.49 6/15/2023324,000 shares $179,755.20 -39.9%1.8%0.2 $0.55 5/31/2023538,800 shares $328,668.00 -67.5%3.0%0.4 $0.61 5/15/20231,660,000 shares $1.05 million +525.9%9.2%1.3 $0.63 4/30/2023265,200 shares $165,935.64 -6.1%1.5%2.1 $0.63 4/15/2023282,500 shares $192,100.00 +28.1%1.5%1.9 $0.68 3/31/2023220,600 shares $161,214.48 -27.7%1.2%1.1 $0.73 3/15/2023305,300 shares $242,835.62 -13.8%1.7%1.4 $0.80 2/28/2023354,100 shares $319,079.51 -16.9%1.9%1.6 $0.90 2/15/2023426,000 shares $415,137.00 +7.6%2.3%1.9 $0.97 1/31/2023395,800 shares $486,834.00 +28.6%2.1%1.1 $1.23 1/15/2023307,900 shares $253,309.33 -19.4%1.7%0.8 $0.82 12/30/2022381,900 shares $244,416.00 -15.2%2.1%0.7 $0.64 12/15/2022450,400 shares $307,262.88 -5.8%2.5%0.9 $0.68 11/30/2022478,300 shares $378,383.13 +14.0%2.9%0.8 $0.79 11/15/2022419,600 shares $351,163.24 -21.9%2.5%0.7 $0.84 10/31/2022537,200 shares $459,467.16 +1,239.7%3.2%1.1 $0.86 10/15/202240,100 shares $32,280.50 -46.5%0.3%0 $0.81 9/30/202275,000 shares $57,937.50 -30.7%0.5%0.1 $0.77 9/15/2022108,200 shares $105,094.66 -72.7%0.7%0.1 $0.97A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. SBFM Short Interest - Frequently Asked Questions What is Sunshine Biopharma's current short interest? Short interest is the volume of Sunshine Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 284,500 shares of SBFM short. 29.84% of Sunshine Biopharma's shares are currently sold short. Learn More on Sunshine Biopharma's current short interest. What is a good short interest percentage for Sunshine Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 29.84% of Sunshine Biopharma's floating shares are currently sold short. Is Sunshine Biopharma's short interest increasing or decreasing? Sunshine Biopharma saw a increase in short interest in April. As of April 30th, there was short interest totaling 284,500 shares, an increase of 307.6% from the previous total of 69,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sunshine Biopharma's float size? Sunshine Biopharma currently has issued a total of 990,000 shares. Some of Sunshine Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sunshine Biopharma currently has a public float of 953,400 shares. How does Sunshine Biopharma's short interest compare to its competitors? 29.84% of Sunshine Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sunshine Biopharma: SciSparc Ltd. (4.18%), Evelo Biosciences, Inc. (2.11%), Lucy Scientific Discovery Inc. (3.32%), Aditxt, Inc. (8.48%), GRI Bio, Inc. (0.46%), China SXT Pharmaceuticals, Inc. (2.63%), NeuBase Therapeutics, Inc. (0.51%), Biodexa Pharmaceuticals Plc (160.06%), Aptevo Therapeutics Inc. (16.76%), Panbela Therapeutics, Inc. (2.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Sunshine Biopharma stock? Short selling SBFM is an investing strategy that aims to generate trading profit from Sunshine Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sunshine Biopharma? A short squeeze for Sunshine Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SBFM, which in turn drives the price of the stock up even further. How often is Sunshine Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBFM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SciSparc Short Interest Data Evelo Biosciences Short Interest Data Lucy Scientific Discovery Short Interest Data Aditxt Short Interest Data GRI Bio Short Interest Data China SXT Pharmaceuticals Short Interest Data NeuBase Therapeutics Short Interest Data Biodexa Pharmaceuticals Short Interest Data Aptevo Therapeutics Short Interest Data Panbela Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SBFM) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetry